A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

NCT00216476 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

753

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Psychotic Disorders

Interventions

DRUG: Aripiprazole
DRUG: Risperidone Long Acting Injectable (LAI)
DRUG: Quetiapine

Sponsor

Janssen-Cilag International NV